Literature DB >> 31994201

Recurrent RET gene fusions in paediatric spindle mesenchymal neoplasms.

Jessica L Davis1, Sara O Vargas2, Erin R Rudzinski3, Jessica M López Marti4, Katherine Janeway5, Suzanne Forrest5, Katrina Winsnes6, Navin Pinto7, Sung E Yang1, Mandy VanSandt1, Theonia K Boyd2, Christopher L Corless1, Yajuan J Liu8, Lea F Surrey9, Marian H Harris2, Alanna Church2, Alyaa Al-Ibraheemi2.   

Abstract

AIMS: The classification of paediatric spindle mesenchymal tumours is evolving, and the spectrum of so-called 'infantile fibrosarcoma' has expanded to include tumours with NTRK, BRAF and MET gene fusions. RET-rearranged paediatric spindle cell neoplasms are an emerging group; there is sparse literature on their clinical, pathological and genetic features, and their nosological place in the canon of soft tissue tumours is uncertain. In this study, we report five RET-rearranged paediatric spindle cell tumours with fusion partners MYH10, KIAA1217 and CLIP2. METHODS AND
RESULTS: The tumours occurred in the pelvic region, paraspinal region, kidney and subcutaneous tissue of hand and abdomen. The patients' ages ranged from 6 months to 13 years (median 1 year). The tumours were composed of monomorphic spindle cells arranged in a fascicular pattern. Lesional cells had minimally atypical ovoid or tapered nuclei and pale cytoplasm with indistinct borders. Necrosis was not identified. Mitoses numbered three to 12 per 10 high-power field. Cases showed inconsistent and variable expression of S100, CD34 and SMA. Clinical behaviour ranged from small lesions potentially cured by simple resection to large lesions exhibiting metastasis, but responsive to kinase inhibitor therapy.
CONCLUSIONS: Our findings help to define RET-rearranged spindle cell tumours. Although it is likely that these tumours comprise part of the morphological and clinical spectrum of infantile fibrosarcoma (IFS), identification of RET gene alteration is important for its unique therapeutic implications.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  RET; infantile fibrosarcoma; paediatric; sarcoma; spindle

Mesh:

Substances:

Year:  2020        PMID: 31994201     DOI: 10.1111/his.14082

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

1.  CIC-Mediated Modulation of MAPK Signaling Opposes Receptor Tyrosine Kinase Inhibitor Response in Kinase-Addicted Sarcoma.

Authors:  Igor Odintsov; Michael V Ortiz; Inna Khodos; Marissa S Mattar; Allan J W Lui; Shinji Kohsaka; Elisa de Stanchina; Julia L Glade Bender; Marc Ladanyi; Romel Somwar
Journal:  Cancer Res       Date:  2022-03-15       Impact factor: 13.312

Review 2.  Malignant Superficial Mesenchymal Tumors in Children.

Authors:  Philippe Drabent; Sylvie Fraitag
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

3.  Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.

Authors:  Steven D Billings; Jennifer S Ko; Josephine K Dermawan; Elizabeth M Azzato; John R Goldblum; Brian P Rubin
Journal:  Mod Pathol       Date:  2021-06-04       Impact factor: 7.842

4.  Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma.

Authors:  Alyssa J Penning; Alyaa Al-Ibraheemi; Michael Michal; Brandon T Larsen; Soo-Jin Cho; Christina M Lockwood; Vera A Paulson; Yajuan J Liu; Lukáš Plank; Karen Fritchie; Carol Beadling; Tanaya L Neff; Christopher L Corless; Erin R Rudzinski; Jessica L Davis
Journal:  Mod Pathol       Date:  2021-04-13       Impact factor: 8.209

Review 5.  RET Gene Fusions in Malignancies of the Thyroid and Other Tissues.

Authors:  Massimo Santoro; Marialuisa Moccia; Giorgia Federico; Francesca Carlomagno
Journal:  Genes (Basel)       Date:  2020-04-15       Impact factor: 4.096

6.  Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients.

Authors:  Sébastien Perreault; Rose Chami; Rebecca J Deyell; Dina El Demellawy; Benjamin Ellezam; Nada Jabado; Daniel A Morgenstern; Aru Narendran; Poul H B Sorensen; Jonathan D Wasserman; Stephen Yip
Journal:  Curr Oncol       Date:  2021-01-09       Impact factor: 3.677

Review 7.  Embryonal and non-meningothelial mesenchymal tumors of the central nervous system - Advances in diagnosis and prognostication.

Authors:  David M Meredith; Sanda Alexandrescu
Journal:  Brain Pathol       Date:  2022-03-09       Impact factor: 7.611

Review 8.  The mechanobiome: a goldmine for cancer therapeutics.

Authors:  Eleana Parajón; Alexandra Surcel; Douglas N Robinson
Journal:  Am J Physiol Cell Physiol       Date:  2020-11-11       Impact factor: 4.249

9.  Infantile fibrosarcoma-like tumor driven by novel RBPMS-MET fusion consolidated with cabozantinib.

Authors:  Ajay Gupta; Jennifer A Belsky; Kathleen M Schieffer; Kristen Leraas; Elizabeth Varga; Sean D McGrath; Selene C Koo; Vincent Magrini; Richard K Wilson; Peter White; Elaine R Mardis; Kris R Jatana; Catherine E Cottrell; Bhuvana A Setty
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-10-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.